Latest Financials News

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

North Stawell Minerals Ltd reported a significant reduction in cash reserves for the quarter ending March 2025, highlighting a potential capital raising as exploration activities near completion.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

West Cobar Metals has identified five high-priority copper-gold targets in Western Australia’s Fraser Range and secured a farm-in deal with Minrex Resources to fund upcoming drilling. Positive metallurgical results at its Bulla Park copper-antimony project and a $450,000 placement underpin its exploration momentum.

Eneco Refresh Limited reports solid 8% year-to-date revenue growth for Q3 FY2025, underpinned by gains in its water and plastics segments and improved cash flow.

Empire Energy Group is advancing its Carpentaria-5H well hydraulic stimulation scheduled for June 2025, alongside preparations for the Carpentaria Gas Plant construction, aiming to commence gas sales from EP187 by late 2025 or early 2026.

The Star Entertainment Group reported a 9% revenue decline to $271 million in Q3 FY25 alongside a $21 million EBITDA loss, driven by seasonal factors and operational challenges. The company is advancing strategic investments and joint venture exits amid ongoing liquidity pressures and regulatory hurdles.

North Stawell Minerals has reported a standout high-grade gold intercept at its Darlington target, reinforcing the potential for a Mariners-type mineralisation repeat in Victoria’s Stawell Corridor. Meanwhile, Wildwood drilling confirms geological promise despite lower grades.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Lode Resources has reported exceptional high-grade antimony and silver drill results from its Montezuma Project in Tasmania, alongside commencing a substantial 50-60 hole drilling program to expand the deposit.

Vonex Limited has appointed Michael Blake as CEO while completing a $13.9 million entitlement offer and refinancing its debt, reinforcing its operational and financial foundation. The company also earned recognition for industry-leading complaint resolution.